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Abstract
Infection with Helicobacter pylori is the major cause for the development of peptic ulcer disease (PUD). In children, with no
other etiology for the disease, this rare event occurs shortly after infection. In these young patients, habits of smoking, diet,
consumption of alcohol and non-steroid anti-inflammatory drugs and stress, in addition to the genetic susceptibility of the
patient, represent a minor influence. Accordingly, the virulence of the implicated H. pylori strain should play a crucial role in
the development of PUD. Corroborating this, our in vitro infection assays comparing a pool of five H. pylori strains isolated
from children with PUD to a pool of five other pediatric clinical isolates associated with non-ulcer dyspepsia (NUD) showed
the greater ability of PUD strains to induce a marked decrease in the viability of gastric cells and to cause severe damage in
the cells cytoskeleton as well as an impairment in the production/secretion of mucins. To uncover virulence features, we
compared the proteome of these two groups of H. pylori strains. Two-dimensional gel electrophoresis followed by mass-
spectrometry allowed us to detect 27 differentially expressed proteins between them. In addition to the presence of genes
encoding well established virulence factors, namely cagA, vacAs1, oipA ‘‘on’’ status, homB and jhp562 genes, the pediatric
ulcerogenic strains shared a proteome profile characterized by changes in the abundance of: motility-associated proteins,
accounting for higher motility; antioxidant proteins, which may confer increased resistance to inflammation; and enzymes
involved in key steps in the metabolism of glucose, amino acids and urea, which may be advantageous to face fluctuations
of nutrients. In conclusion, the enhanced virulence of the pediatric ulcerogenic H. pylori strains may result from a synergy
between their natural ability to better adapt to the hostile human stomach and the expression of the established virulence
factors.
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Introduction
Helicobacter pylori is a spiral-shaped, microaerophilic, gram-
negative bacterium that inhabits the human stomach. Depending
on the socioeconomic status of the country, the prevalence of
infection varies from 40 to over 80% of the population, with
higher rates for developing countries [1]. Infection is usually
acquired during childhood and always elicits an acute immune
response which, in the absence of effective treatment, persists
throughout the patient’s life, resulting in chronic gastritis.
Although this condition may be asymptomatic, some patients
develop dyspeptic symptoms, i.e., the so-called non-ulcer dyspepsia
(NUD) [2]. In about 15% of infected patients, gastritis may
progress further to severe gastric diseases, namely peptic ulcer
disease (PUD) and gastric cancer (GC) [1,3].
PUD is a multifactorial disease which leads to considerable
patient morbidity and mortality [4]. It is considered to be a disease
of adulthood being its progression highly dependent on environ-
mental factors, such as the use of non-steroid anti-inflammatory
drugs (NSAID), alcohol consumption, diet, smoking and stress.
Some viral infections (e.g. cytomegalovirus and herpes simplex
infections), Crohn’s disease and syndromes where an increase in
acid secretion occurs (e.g., Zollinger-Ellison syndrome), may also
contribute to the onset of PUD [4]. However, a long-term
infection with H. pylori is considered as the major causative factor
for PUD. This is easily demonstrated by the high number of
patients infected with H. pylori among those who are affected by
PUD, and by the fact that, with the successful eradication of the
bacteria, non-NSAID-related PUD is healed and rarely recurs
[2,4]. PUD can be subdivided into duodenal ulcer (DU) and
gastric ulcer (GU) diseases which are considered divergent. DU is
basically a duodenal acid injury that results from acid hyperse-
cretion due to infection of the antrum by H. pylori [2]. In contrast,
GU is usually associated with acid hyposecretion that results from
the gastric atrophy caused by a proximal spread of the infection,
and hence, of inflammation [2]. Supporting differences in the
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pathogenesis of these two clinical outcomes, the prevalence of H.
pylori infection is higher than 95% in DU cases and around 60% to
80% in GU [5,6].
The development of PUD in H. pylori infected children is a very
rare event and usually occurs soon after infection. In Portugal, for
example, only about 2% of the estimated 40% of the Portuguese
infected children suffer from this disease [7]. Besides genetic
susceptibility [8], the aforementioned environmental factors
should have a minor influence on the pathogenesis of PUD in
infected children. Therefore, we believe that the virulence factors
of the implicated strain must play a crucial role in the onset of
PUD in children [2]. We have reported some data on genetic
studies of clinical isolates which show the association of some
bacterial genes with the development of PUD in infected children
[9–12]. Indeed, in addition to the most well known virulence
factors, namely the cytotoxin-associated gene A (cagA) gene, the ‘‘on’’
genotype (i.e., functional) of the outer inflammatory protein A (oipA)
gene, the s1/m1 allele of the vacuolating cytotoxin gene (vacA), and the
A2 allele of the blood group antigen binding adhesin (BabA) gene [1,3],
we found that homB and jhp562 genes are closely associated with
PUD in children and may be useful in determining the clinical
outcome of infection [9–12]. HomB protein is an antigenic outer
membrane protein which was shown to be involved in the host
inflammatory response, inducing the secretion of interleukin-8
(IL8), and in the adhesion of H. pylori to gastric epithelial cells
[9,10]. The jhp562 gene encodes a glycosyltransferase involved in
the synthesis of lipopolysaccharide and may also be implicated in
the regulation of Lewis antigen expression [12]. The presence of
the triple genotype cagA, jhp562 and homB in H. pylori strains
provides a good discriminatory basis to distinguish PUD and NUD
outcomes in infected children [12].
Motivated by these findings, we further characterized five H.
pylori strains, isolated from Portuguese children with PUD, all
positive for cagA, jhp562 and homB genes. Their virulence profile
was first compared to that of five other clinical isolates collected
from children with NUD, by co-culture assays with the NCI-N87
cell line (American Type Culture Collection (ATCC) CRL 5822).
We report here the differences that we found in the impact of these
two groups of H. pylori strains on the viability, phenotype and
cytoskeleton organization of the NCI-N87 cells. Moreover, in
order to understand the molecular mechanisms that underlie their
more pathogenic phenotype, we compared the proteomes of the
ulcerogenic H. pylori strains with those of the NUD strains.
Results
Ten H. pylori strains isolated from Portuguese pediatric patients,
five suffering from NUD (mean age 10.2 years, range 7 to 14) and
five other affected by PUD (mean age 11.8 years, range 10 to 15,
having no other etiology for the disease), were carefully selected to
be genetically homogeneous within the respective group (Table 1).
The difference between the mean ages of these two groups was not
statistically significant. According to their previously reported
genotype [12], all PUD strains were positive for some important
virulence factors associated with PUD in children. These include
cagA, vacA s1 (i.e., the toxic allele), oipA ‘‘on’’, homB and jhp562 (with
the exception of strain 1846/05) genes (Table 1). In contrast, all of
the NUD strains were cagA, homB and jhp562 negative and carried
the oipA ‘‘off’’ status and the vacA s2 (i.e., the non-toxic allele) gene
(Table 1).
Co-culture assays
To clarify whether the virulence of the strains was the
determining factor for the development of PUD in children from
whom they were collected, we compared their impact on human
gastric epithelial cells with that of NUD strains, by in vitro infection
experiments. These experiments were carried out using the NCI-
N87 cell line, known for its unique differentiation status as it is able
to form coherent monolayers, expressing the correct cellular
distribution of both E-cadherin and ZO-1 junction proteins [13].
Confluent NCI-N87 cells monolayers were thus incubated in
parallel with two different pools of H. pylori strains, one including
the five PUD associated strains, and another including the five
NUD strains, both at a multiplicity of infection (MOI) of 100.
Under our experimental co-culture conditions, the viability of
NCI-N87 cells was clearly reduced over time with both pools of H.
pylori strains (Figure 1). However, this effect was more pronounced
in the first hours following infection with the pool of PUD-
associated strains. Indeed, cell viability was significantly lower
(p,0.05) in NCI-N87 cells infected with PUD-H. pylori strains at
Table 1. Characterization of the H. pylori strains included in the study and of the patients from whom each of them was isolated.
H. pylori Patient
Strain cagA vacA oipA homB jhp562 Histologic Analysis Age Gender
173/00 2 s2 off 2 2 NUD 14 M
207/99 2 s2 off 2 2 NUD 7 F
228/99 2 s2 off 2 2 NUD 8 M
655/99 2 s2 off 2 2 NUD 11 M
1786/05 2 s2 off 2 2 NUD 11 M
499/02 + s1 on + + GU 11 M
1089/03 + s1 on + + DU 10 M
1152/04 + s1 on + + DU 10 M
1198/04 + s1 on + + DU 15 M
1846/05 + s1 on + 2 DU 13 M
All strains are indicated by their collection number. All patients were from Portugal. In columns cagA, homB and jhp562: + indicates strain containing the gene;2 indicates
strain lacking the gene. vacA column: s1 indicates strains containing the toxic allele of the gene; and s2, strain containing the non-toxic allele of the gene. oipA column: on
indicates strains containing the functional allele of the gene; and off, strains containing the non-functional allele of the gene. NUD - non-ulcer dyspepsia; DU – duodenal
ulcer; GU – gastric ulcer. M - Masculine; F - Feminine.
doi:10.1371/journal.pone.0026265.t001
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1 h (89.90%66.23) and 12 h post-infection (73.14%68.96),
compared to cells infected with NUD strains (99.80%63.52 and
89.94%66.70, respectively) (Figure 1). At 24 h post-infection, the
viability of the epithelial cells was very low in both cases,
5.40%64.51 and 10.78%611.91, for cells infected with NUD and
PUD strains, respectively (Figure 1). However, the morphological
analysis of the remaining cells (Figure 2) showed dramatic
differences in the impact of each pool of H. pylori strains. Indeed,
light microscopy observations revealed much more pronounced
cell damage in NCI-N87 cells infected with the pool of PUD-H.
pylori strains (Figures 2A, 2B and 2C). Moreover, the pool of PUD
strains caused the total destabilization of the NCI-N87 cells’
microtubule network, as demonstrated by the immunocytochem-
ical assays (Figures 2F), which seemed almost unchanged in cells
infected with NUD-H. pylori strains (Figure 2E). In addition,
epithelial cells infected with the PUD-H. pylori strains showed a
drastic reduction in the cytoplasmic Periodic Acid Schiff (PAS)
reactivity (Figure 2G, 2H and 2I), which was supported by the
destruction of the cell membrane observed with hematoxylin and
PAS double staining (Figure 2J, 2L and 2M). We also observed
that the nuclear envelope of the NCI-N87 cells infected with the
H. pylori strains associated with PUD was undisrupted, despite
having a very irregular appearance, suggesting cell death by
necrosis (Figure 2I and 2M). In contrast, NCI-N87 cells co-
cultured with the NUD-associated H. pylori strains showed an
accumulation of extracellular vesicles positive for PAS (dark arrow
in Figure 2L) suggesting the expected exocytosis of intracellular
mucus-containing vesicles, also observed in the non-infected
control (data not shown). After 24 h of co-culture, NUD strains
maintained their bacillary shape and were adherent to the
epithelial cell surface (Figure 2H and 2L), however, PUD strains
acquired a coccoidal shape (Figure 2I and 2M) which was already
observed at 12 h post infection (data not shown).
H. pylori proteome profile
Total soluble protein extracts from each of the 10 H. pylori
strains were resolved by 2-dimensional gel electrophoresis (2DE),
first in a non-linear pH range of 3–11 and then in a 7–16% (w/v)
SDS-PAGE. After Coomassie Brilliant Blue (CBB) staining, the
digitalized images of the gels were analyzed using the ImageMas-
terTM 2D Platinum software. Protein spots were automatically
detected and manually corrected and the best resolved 2DE-gel,
that of NUD-associated H. pylori strain 655/99, was used as the
reference map during computer assisted analysis. After automatic
matching, followed by a manual correction, gels were separated
into two classes, NUD and PUD, according to the pathology with
which the strain was associated. Gel-to-gel matching was con-
firmed by MS identification of matched spots from different 2DE
gels. The 2DE maps obtained for each group of strains were found
to be highly reproducible and consistent (Figure 3). No statistically
difference was observed for the number of detected spots (on
average 485677 vs. 443643 in NUD and PUD 2DE gels,
respectively) between these two classes.
Comparative proteomic analysis
In order to search for a protein signature for pediatric H. pylori
PUD-associated strains, a computer-assisted analysis was per-
formed by statistical evaluation of changes in the % Vol, i.e., the
normalized volume, for each protein spot within the two disease-
associated classes of 2DE gels. As a result, irrelevant variations
between images were eliminated. From this analysis, we observed
that the proteome of the H. pylori strain 499/02, the unique strain
associated with GU, was not fully consistent with the proteome of
the other four strains included in the group of PUD related strains
isolated from children with DU. Therefore, from this point
onward the strain 499/02 was analyzed separately. Table 2 lists
the identification by peptide mass fingerprinting (PMF) analysis
and/or by comparison with 2DE databases [14] of 26 protein
spots detected as being differentially expressed: 24 of them were
statistical significant (p,0.05) between the NUD and DU classes of
strains; and one spot detected at a different position within the
2DE-gels.
These include 15 proteins which were highly abundant in DU-
associated H. pylori strains (solid arrows in Figure 3; upward arrows
in Table 2), when compared to NUD strains: flagellar hook protein
(FlgE, spot 2) and flagellin A (FlaA, spot 3), both components of
the bacteria’s flagella; the heat shock protein B (HspB, spot 4), a
homolog of Hsp60 involved in protein folding; both beta and
alpha subunits of urease (UreB, spot 5, and UreA, spot 20), which
catalyzes the hydrolysis of urea into ammonia and CO2;
phosphoglycerate kinase (Pgk, spot 12), 3-dehydroquinate dehy-
dratase (AroQ, spot 22) and flavodoxin A (FldA, spot 25), involved
in bacteria metabolic cycles; putative aldo-keto reductase (spot 15),
a protein of the cell detoxification system; an isoform of UPF0174
protein HP_1588 (spot 17), a protein whose function is unknown;
the non-heme iron-containing ferritin (Pfr, spot 23), involved in
iron metabolism; the virulence factor neutrophil activating protein
(NapA, spot 26); and the HPG27_1480 protein (spot 27),
homologous to the HP1542 protein which has a putative function
in cell shape [15]. Interestingly, a thirteenth protein, the
hypothetical protein HPAG1_1081 (spot 13), was detected
exclusively in the DU- associated H. pylori strains. This protein is
a homolog of HP1143, another protein with a putative function in
cell shape [16]. Further experiments are needed to clarify whether
the expression of this protein is unique to the DU strains, or it also
occurs in NUD and GU strains but at levels below our detection
threshold. As previously shown, only the PUD-H. pylori strains
were cagA positive and this was confirmed by the total absence of
CagA protein in the 2DE maps of the NUD-strains. This protein
corresponds to spot 1 in the PUD-2DE maps (Figure 3; Table 2).
Amongst the group of differentially expressed proteins, we
found the following 11 protein spots to be less abundant in DU-
Figure 1. Impact of the two isogenic groups of pediatric H.
pylori strains on NCI-N87 cells viability. The viability of NCI-N87
cells was assessed by the trypan blue exclusion assay after 1, 12 and
24 h of co-culture with a pool of five pediatric PUD-associated strains
(& in full line) and a pool of five pediatric NUD-associated strains (N in
dashed line). For normalization, the value of 100% corresponds to the
viability of non-infected NCI-N87 cells. * indicates values that were
determined as significantly different (p,0.05) between the viability of
cells infected with PUD strains and that of cells infected with NUD-
strains at the same time-point of co-culture. Symbols and error bars are
means 6 SD of the values at each point for 3 observations.
doi:10.1371/journal.pone.0026265.g001
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associated H. pylori strains (dotted arrows in Figure 3; downward
arrows in Table 2), when compared with NUD strains: hydantoin
utilization protein A (HyuA, spot 6), aspartate ammonia-lyase
(AspA, spot 11), succinyl-CoA-transferase (SCOT) subunits A and
B (ScoA and ScoB, spots 19 and 21, respectively), pyruvate
flavodoxin oxidoreductase, gamma subunit (Porc, spot 24),
proteins involved in bacteria metabolic cycles; ribosomal protein
S1 (RpsA, spot 8) and cysteinyl-tRNA synthetase (CysS, spot 10),
proteins involved in protein biosynthesis; catalase (KatA, spot 9),
involved in the cell detoxification system; HELPY_0944 (spot 16),
homologous to HP0958, which is a protein with a putative
function in cell motility; and another isoform of UPF0174 protein
HP_1588 (spot 18), a protein whose function is unknown. Spot 7,
which we were unable to identify, was only detected in NUD
strains, with the exception of the H. pylori strain 228/99. As before,
we cannot say that the expression of this protein is completely
absent in DU strains, rather that its expression levels were below
our detection threshold.
Besides differences in protein expression between these two
groups of strains, we detected a difference in the position of the
protein spot 14 within the 2DE-gel (Figure 3) that was identified as
being elongation factor Ts (EF-Ts) (Table 2). Indeed, in the 2DE-
maps of the DU strains, this protein spot was shifted to the right
relative to its position in the NUD 2DE-maps (Figure 3).
Interestingly, we found differences in the abundance of some of
these protein spots in GU-associated H. pylori strain 499/02, when
compared to that of the DU strains (Figure 3; Table 2). Showing
the same tendency of that observed in DU strains compared to
NUD strains, we found FlgE (spot 2), FlaA (spot 3), Pgk (spot 12)
and aroQ (spot 22). Showing the opposite tendency of that
observed for DU strains compared to NUD strains, and with
abundance levels similar to those observed in the latter group of
strains, we found UreB (spot 5), HPAG1_1081 (spot 13), putative
aldo-keto reductase (spot 15), one isoform of the HP_1588 (spot
17), and UreA (spot 20). CagA (spot 1) was less abundant in the
GU strain (Table 2). All of the other protein spots followed the
same pattern of expression observed for the H. pylori strains
associated with DU (Table 2).
Although the MOWSE score in the MS identification did not
reach statistical significance (p.0.05) for the CagA (spot 1), CysS
(spot 10), AspA (spot 11), ScoA (spot 19), Pfr (spot 23) and
HPG27_1480 (spot 27) protein spots, we are confident in our
Figure 2. Impact of the two isogenic groups of pediatric H. pylori strains on the NCI-N87 cells morphology. NCI-N87 cells grown to 80–
90% confluence were co-cultured for 24 h with the pool of five isogenic NUD-associated H. pylori strains (NUD) and in parallel with the pool of five
isogenic PUD strains (PUD). The control corresponds to non-infected NCI-N87 cells. A), B), and C) light microscopy observations. D), E), and F)
immunodetection of the microtubule network (green) (1:1000 a-tubulin antibody plus a FITC conjugated secondary antibody). G), H), and I) PAS
staining alone, and in J), L), and M) in conjugation with hematoxylin. Dark arrow indicates extracellular vesicles that reacted with PAS.
doi:10.1371/journal.pone.0026265.g002
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results because the same identification was obtained for equivalent
spots from different 2DE gels and it also matched with the
identification in the 2DE H. pylori database [14].
Motility assay
As there were proteins related somehow to bacteria motility
included in the group of proteins which were expressed differen-
tially between NUD and PUD strains, we further evaluated
whether this was translated into differences in motility. Accord-
ingly, the pools of five NUD strains and of five PUD strains under
study were inoculated in an agar motility medium and, at 5, 7 and
11 days the diameter of the growth halo was measured (Figure 4).
In agreement with the higher abundance of FlgE (spot 2), FlaA
(spot 3) in PUD strains (both in DU and GU strains), the H. pylori
strains associated with PUD in children showed bigger growth
halos (Figure 4), indicating that they have higher motility than the
strains associated with NUD. These experiments were carried out
twice, leading to consistent results.
Discussion
The development of PUD in children is a rare consequence of
infection by H. pylori. Environmental factors should have a minor
influence on its pathogenesis since pediatric PUD develops soon
after infection. Its dependence on the genetic susceptibility of these
children is still poorly understood. The expression of sialyl-Lewis
(x) antigens in gastric epithelial cells in association with H. pylori-
dependent DU in pediatrics was recently reported. However, in
contrast to the aberrant expression found in adults patients, the
gastric mucosa of these children presents a normal pattern of
Figure 3. Profile of the soluble proteome of the 10 studied pediatric H. pylori strains. These include five strains associated with NUD (173/
00, 207/99, 228/99, 655/99 and 1786/05), four from patients affected by DU (1089/03, 1152/04, 1198/04 and 1846/05) and a strain associated with GU
(499/02). Proteins from the total biomass recovered from a 24 h grown plate were separated by 2DE, i.e., first in a non-linear pH 3–11 and than in a 7–
16% (w/v) SDS-PAGE. After CBB-staining, gels were analyzed using ImageMasterTM 2-D Platinum software. Black arrow indicates spots that were more
abundant in PUD (DU+GU) strains when compared to NUD strains; Dotted arrow indicates spots that were less abundant in PUD (DU+GU) strains
when compared to NUD strains; Dashed arrow indicates the spot that was shifted right in DU strains when compared to NUD strains. Spot numbers
indicated in the 2DE maps are the same as used in Table 2.
doi:10.1371/journal.pone.0026265.g003
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expression and glycosylation of MUC6 or MUC2 [8]. Moreover,
the susceptibility associated to male gender has been described and
the hypothesis that female hormones, before the onset of the
menopause, somehow protect against the development of PUD
has been raised [17,18]. In agreement, we have recently reported
that pediatric PUD is significantly more frequent in boys than in
girls (63.6% vs 36.4%, p,0.025) when analyzing a large cohort of
1,115 Portuguese children [19]. Notwithstanding, the involvement
of more pathogenic strains is surely a key factor in pediatric H.
pylori-dependent PUD, as was clearly demonstrated by our
previous reported data [9]. In order [10–12] to better characterize
the virulence of such strains, we studied a group of five H. pylori
strains isogenic for important virulence factors associated with
pediatric PUD, namely cagA, vacA s1 allele, oipA ‘‘on’’, homB and
jhp562 (with the exception of the strain 1846/05) genes (Table 1).
These were compared to another group of five strains, isolated
from Portuguese children presenting NUD, all negative for those
virulence factors (Table 1).
In agreement with the more pathogenic behavior of PUD H.
pylori strains, our co-culture assays showed that, indeed, the five
PUD-associated strains, when pooled together, caused a more
pronounced reduction in the viability of NCI-N87 cells than the
pool of five NUD-associated strains (Figure 1). In contrast to
NCI-N87 cells in co-culture with NUD strains, the remaining
epithelial cells after 24 h of co-culture with PUD strains
presented a dramatic destabilization of the microtubule network
(Figure 2F) and a decrease in the cytoplasmic reactivity to PAS
(Figure 2I), suggesting lower amounts of mucins . These results
are consistent with the decreased levels of mucins observed in
gastric biopsies of infected adult patients with PUD and in cell
lines in co-culture with H. pylori strains positive for both cagA and
vacAs1 genes [20,21]. Double staining with PAS and hematoxylin
showed that H. pylori PUD strains induce the destruction of the
cytoplasmic membrane of some host cells, leading them to
release their cytoplasmic content (Figure 2M). This is similar to
necrosis, a required step in the PUD pathogenesis process.
Probably due to changes in environmental conditions caused by
massive cell death, PUD strains acquired a coccoidal form
(Figures 2I and 2M). This phenotype was already observed at
12 h of co-culture.
Taking advantage of our pediatric strains, we decided to
evaluate the proteome of each of the 10 Portuguese H. pylori
strains. Their proteome profiles were consistent (Figure 3) and
comparable with proteome profiles in databases [14]. Moreover,
27 proteins were found to be differentially expressed between PUD
and NUD strains (Table 2). It should be stressed that these
differences in protein expression profile are intrinsic to the bacteria
and were not induced by the environment. In fact, despite having
experienced completely different environmental conditions in vivo,
in this study they were grown under the same controlled
conditions which did not fully resemble their natural niche. An
important observation was noted for the group of PUD-associated
strains: the strain 499/02 presented unique features which
required special attention given that it was isolated from a child
with GU and the other four were associated with DU. Although
these diseases share important molecular mechanisms in their
pathogenesis, they are characterized by different patterns of
colonization, gastritis and gastric acid secretion [2]. Our results
suggest that the ability to induce one of these situations is reflected
in the proteome of the implicated H. pylori strains and should be
investigated further. Thus, the strain 499/02 was considered
separately in the subsequent analysis. Figure 5 resumes the
following discussion of the differentially expressed proteins
grouped according to their known function. We were not able to
identify spot 7 but its role should be important role as it was absent
from the proteome of all PUD strains.
Motility
For efficient colonization of the gastric niche, H. pylori depends
on its ability to swim [22]. The results of the five pediatric strains
associated with PUD (Figure 4) show higher levels of FlgE (spot 2)
and FlaA (spot 3) compared to NUD strains, justifying their
enhanced motility. We must stress that spot 3 may result from the
overlap of FlaA and FlaB (flagellin B), another component of the
H. pylori flagellum filament, both having equal pI and similar
molecular weight (53 and 54 kDa, respectively). If that is the case,
our results reflect a change in the abundance of both FlaA and
FlaB.The abundance of HELPY_0944 protein (spot 16) was
decreased in the five PUD strains compared to the NUD strains.
Despite its homology with the protein HP0958 (H. pylori strain
26695), these results point to a different cellular function for these
two proteins. Contrary to our data on the expression of FlgE, FlaA
(and FlaB) and HELPY_0944 proteins, HP0958 mutants result in
non-flagellated strains, showing a total abrogation of flgE and flaB
transcription [23,24] and very low levels of FlaA [25]. In fact,
HP0958 protein is known to induce the transcription of flgE and
flgB through stabilization of the RNA polymerase sigma factor
RpoN [23,24] and the synthesis of FlaA in an RpoN-independent
manner [25].
Figure 4. Motility of the two isogenic groups of pediatric H.
pylori strains in study. The five strains of each class, recovered from
24 h grown plates, were pooled together, inoculated on semi-solid BHI
broth25% FBS medium plates and incubated for 11 days at 37uC under
microaerophilic conditions. A) The growth halo observed at day 5 for
the pool of PUD and of NUD strains. B) Variation of the diameter of the
growth halo along the time (& in full line refers to PUD strains and N in
dashed line refers to NUD strains). Symbols are means of the values at
each point for 2 observations.
doi:10.1371/journal.pone.0026265.g004
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Besides its polar flagella, H. pylori’s spiral morphology is a
requirement for its motility. In line with this, HPAG1_1081 (spot
13) was exclusively detected in DU-H. pylori strains. HPAG1_1081
is a homolog of HP1143, a coiled-coil protein with a predicted
intermediate filament-like function [26], thus contributing to the
morphology maintenance [16]. HPG27_1480 protein (spot 27),
another protein found more abundantly in all PUD strains, is
homolog to HP1542, a protein involved in spiral shape
maintenance [15].
Antioxidant system
For a sustained infection of the inflamed gastric mucosa,
characterized by the presence of large amounts of reactive oxygen
species (ROS), H. pylori depends on the concerted activity of
several proteins for its antioxidant defense [27]. Here we report
higher levels of Pfr (spot 23) and NapA (spot 26) proteins and lower
levels of KatA (spot 9) for the PUD strains.
Pfr is an essential protein for H. pylori which serves as a storage
of iron in a bioavailable form [28]. Thus, besides protecting the
bacterium against oxidative stress caused by the iron-mediated
Fenton reaction in the presence of excessive amounts of this ion,
Pfr also guarantees the necessary amount of iron for the normal
metabolism of the cell under iron-limited conditions [29]. Like Pfr,
NapA is capable of sequestering iron under oxidative stress
conditions and these two share a protective role of the bacterial
DNA [30]. NapA is, however, better known for its role in
mediating the adhesion of H. pylori to host mucins and its ability to
recruit neutrophils and monocytes to the infected gastric mucosa,
inducing the secretion of chemokines [31]. According to the
literature, abnormally high levels of NapA are expressed in mutant
strains lacking KatA. Instrumental in catalyzing the decomposition
of H2O2 into H2O and O2 [27], this enzyme has been described as
being essential to the survival of H. pylori in a sustained long-term
inflammation [27]. We therefore propose that the NUD strains
analyzed in this study are prepared to resist in a long-term but less
aggressive inflammation. However, the five pediatric strains
associated with PUD are able to survive an acute inflammation
that results in the early development of PUD.
Two isoforms of HP1588 protein (spots 17 and 18) were also
differentially expressed between PUD and NUD strains. The exact
function of this protein is not known although some studies
indicate a potential role in stress resistance, as it is over-expressed
under acidic [32] or iron starvation conditions [33].
Acid Resistance
Urease is a key enzyme in the colonization and persistence of H.
pylori, playing a central role in the bacteria resistance to gastric
acidity by catalyzing the hydrolysis of urea into ammonia and
Figure 5. Schematic diagram of the DU development in children upon H. pylori infection. The virulence of the pediatric PUD-associated H.
pylori strains results from a synergy between their natural ability to better adapt to the hostile human stomach and their virulence factors. Adaptation
is ensured by: higher motility (q FlaA, q FlgE, Q HELP_0944, q HPAG1_1081, and q HPG27_1480), higher ability to survive under low pH
conditions (q UreA and B and q putative aldo-keto reductase), better antioxidant defenses against inflammation (q Pfr, q NapA and Q KatA),
modified metabolism (Q HyuA, Q AspA, q Pgk, Q ScoA and B, qAroQ, Q Porc, q FldA, Q RpsA and Q CysS), adhesion (indicated by a anchor)
mediated by ‘‘on’’ OipA and HomB. Virulence factors (indicated by a bomb): cagA and VacAs1. 1 – Infection; 2 – Host response (acid hypersecretion
and inflammation); 3 – duodenal acid injury (Duodenal Ulcer, indicated by an explosion symbol). Dotted arrow - Time line.
doi:10.1371/journal.pone.0026265.g005
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CO2. Ammonia is, however, cytotoxic to the host cells, causing
their necrosis. This multimeric protein of approximately 1100 kDa
is composed of twelve small subunits, UreA (27 kDa), and twelve
large subunits, UreB (62 kDa) [34]. In agreement with our
previous findings [35], urease (UreA plus UreB) was one of the
most abundant proteins in the proteome of all of the H. pylori
strains in the current study. However, the strains collected from
children with DU had higher levels of both UreA and UreB, than
either the NUD or the GU strains. Higher levels of HspB (spot 4),
a protein which functions as an extracellular chaperonin for urease
[36] among other key roles, were observed in all PUD strains.
According to the literature, excessive urease activity under
neutral conditions is lethal to the bacteria [34]. Considering that
no difference was detected neither in the growth rate nor in the
urease activity among these pediatric strains at pH 7 (results not
shown), we hypothesize that the highest amount of urease
produced by the DU strains does not reflect a higher activity per
se. Instead, urease activity must be acid–dependent and thus, once
in their natural niche, DU strains are better protected against a
sudden drop in pH and/or in Ni2+ concentration which explains
their ability to survive under abnormally acidic conditions [34].
Moreover, since urease has also been proposed to play a role in
adherence to gastric mucins [37], again in a acid dependent
manner [38], higher levels of urease may facilitate the processes of
colonization and infection, contributing to the ulcerogenic
phenotype of DU strains.
Lastly the putative aldo-keto reductase (spot 15) was also found
to be more abundant in DU strains. It was described as an
essential enzyme for growth at acidic pH [39], and is involved in
the removal of toxic aldehydes and ketones of the cell. Again, the
abundance of this protein in the proteome of the GU-associated
strain 499/02 was equivalent to that in NUD strains, further
corroborating the idea that only the DU-associated pediatric H.
pylori strains are prepared to face a hyper-acidic environment.
Metabolism
Among the proteins expressed differentially between NUD and
PUD strains, there were 10 proteins involved in the metabolism of
the bacterium.
A lower abundance of HyuA (spot 6), the enzyme responsible
for the conversion of N-methyl hydantoin to N-carbamoyl
sarcosine, was observed in all PUD-associated H. pylori strains.
Not much is known about the role of this protein in H. pylori but
this was described as a key step in the metabolism of creatine in
other bacteria [40], a final pathway in the urea cycle and amino
acid metabolism. Whether this may favor the endogenous
production of urea we do not know and it should be investigated.
In line with our findings, other authors have indicated HyuA as a
biomarker for GC, since positive antibodies against it were found
in sera from patients suffering with GC but not with PUD [41,42].
Interestingly, AspA (spot 11), the enzyme that by catalyzing the
deamination of Asp to fumarate ensures the aneuplerotic
replenishment of the latter in Krebs cycle [43,44], was in low
abundance in all PUD strains compared with NUD strains. Asp
and fumarate link the Krebs cycle to the urea cycle [45], therefore,
we may suppose that in the former group of strains, Asp is
primarily involved in the urea cycle with the concomitant
production of urea. However, as H. pylori uses amino acids as a
primary source of carbon, nitrogen and energy, with Asp being
one of the eight most consumed amino acids [46], we cannot rule
out that in PUD strains, Asp is used in the biosynthesis of Asp-
derived amino acids. Indeed, the metabolism of amino acids was
recently connected to virulence, colonization and stress resistance
of H. pylori [46]. In H. pylori, the Krebs cycle is characterized by the
absence of succinate dehydrogenase [44]. Although controversial,
the SCOT complex which catalyzes the conversion of succinyl-
CoA to succinate in an acetoacetate-dependent manner was
proposed to substitute the missing enzyme [47]. Here H. pylori
strains isolated from children with PUD presented lower levels of
both subunits of the SCOT-complex, ScoA and ScoB (spots 19
and 21, respectively) which suggests a down-regulation of its
catalytic activity.
Since H. pylori is a microaerophilic organism, the initiation of
the Krebs cycle, i.e. the oxidative descarboxylation of pyruvate is
catalyzed by an oxygen sensitive enzyme, pyruvate flavodoxin
oxidoreductase (POR), instead of the aerobic pyruvate dehydro-
genase or the strictly anaerobic pyruvate-formate lyase. Although
its stoichiometry is unknown, POR is composed of four subunits,
all essential for the in vitro viability of H. pylori. These are encoded
by the porCDAB operon [48]. In this reaction, the FldA protein is
the electron acceptor [43,44,49], a low potential one, which in
turn is re-oxidized by the flavodoxin-quinone reductase (FqrB),
generating NADPH. In vitro experiments have shown that POR is
the rate limiting enzyme in this pathway [50]. The reverse reaction
of this POR-FldA-FqrB-NADP reductase complex is believed to
be important in the fixation of CO2, which is essential for
replenishing pyruvate consumed by gluconeogenesis [50]. Inter-
estingly, we found significantly lower levels of one isoform of the
PORc subunit (spot 24), encoded by the porC gene, in the pediatric
PUD-associated H. pylori strains compared to the NUD strains. As
far as we known, the role of PORc subunit and its isoforms in the
POR complex is still unclear. However, because of the observed
higher levels of FldA (spot 25), we interpret our findings as PUD
strains having a more functional POR. In this case, we would
expect a higher production of NADPH and acetyl-CoA in PUD
strains. Further experiments are needed to clarify this. Moreover,
the Pgk protein (spot 12), a glycolytic/gluconeogenic enzyme
which catalyzes the reversible conversion of 1,3-biphosphoglyce-
rate into 3-phosphoglycerate [44], was found to be more abundant
in the DU-associated strains and even more abundant in the GU
related H. pylori strain.
Chorismate, a precursor of aromatic amino acids, is formed
from phosphoenol pyruvate and erythrose 4-phosphate by means
of seven enzymes [44]. AroQ (spot 22), an enzyme that catalyzes
the conversion of 3-dehydroquinate into 3-dehydroshikimate
which is a key step in chorismate synthesis, showed an augmented
expression in DU-associated H. pylori strains and, again, an even
higher expression in the GU strain. This is suggestive of an
enhancement in aromatic amino acid biosynthesis in DU strains
compared to NUD strains and even more pronounced in the GU
strain over all of the other [51].
In H. pylori, amino acids in excess of those needed for protein
synthesis cannot be stored and are catabolised. Our data point out
that this ability is potentiated in the pediatric PUD-H. pylori strains.
In fact, lower levels of both RpsA (spot 8), one of the 21 ribosomal
proteins of the small 30S subunit [44], and aminoacyl-tRNA
synthetase CysS (spot 10) were observed for these strains when
compared to NUD strains. These data suggest a down-regulation
of translation in general saving amino acids for degradation. If that
is the case, the aforementioned higher levels of HspB registered for
PUD strains would also play an important role in avoiding protein
misfolding. The elongation factor EF-Ts (spot 14), also involved in
translation, showed a shift in 2DE gels of DU strains, suggesting a
post-translational modification which may influence its activity. In
fully agreement with these results, two studies reported that under
stress, nutritional or low pH conditions, the stringent response of
H. pylori included the down-regulation of ribosomal genes and of
aminoacyl-tRNAs and, in contrast, the enhancement of amino
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acid biosynthesis [44,52]. The beauty of the data presented here is
that are not induced by stress conditions but, as mentioned above,
are intrinsic to PUD strains, making them much more adapted
and, therefore, virulent.
Virulence factors
As already mentioned, all of the H. pylori strains associated with
PUD in children that we have analyzed carried the genes of some
well known virulence factors (Table 1) from which we could only
detect the expression of cagA. CagA (spot 1 in our 2DE gels) which
is known to induce abnormal proliferation, disruption of tight
junctions, cytoskeleton rearrangements and IL-8 secretion in the
host cells [53], was less abundant in the GU strain when compared
to the other four DU associated strains.
It was important to disclose whether the special features of the
proteome profile of the PUD-H. pylori strains of this study were
linked to their cagA/vacAs1 positive genotype. For that, we checked
the abundance of the aforementioned 26 proteins in the proteome
of ten other Portuguese H. pylori strains isolated from children and
adult patients with NUD and from adults patients with PUD and
GC (five cagA/vacAs1 positive and five others negative for these
virulence factors), all currently under study in our lab. Of those
proteins, only HspB and Pfr showed a pattern of abundance in the
comparison between cagA positive and negative strains (data not
shown) similar to that presented when comparing pediatric PUD
and NUD strains (data from this study). This supports our
hypothesis that the pediatric H. pylori strains associated with PUD
present a specific protein signature which provides them a natural
ability of adaptation to the human stomach. This profile combined
with the expression of virulence factors (cagA, vacAs1, oipA ‘‘on’’
status, homB and jhp562) appears to be responsible for their
enhanced virulence. Asian isolates which present marked differ-
ences in their genetic background compared to European strains,
namely being nearly all positive for cagA, are an interesting group
to study in the future.
Conclusion
The data that we report here clearly show that the pediatric
ulcerogenic H. pylori strains in our study share a particular
proteome profile that, in addition to the well established virulence
factors, provides them with higher motility. They also highlight for
the strains’ better antioxidant defenses and metabolism favoring
the biosynthesis of aromatic amino acids, perhaps to be used as
source of energy. Additionally, DU strains are apparently better
fitted than all the other studied strains to survive under low pH
conditions, which may justify their survival following acid
hypersecretion which is characteristic of this disease. We believe
that the virulence of pediatric ulcerogenic strains is strongly
dependent on the synergy of their well established virulence factors
and their better adaptation to the natural niche. Despite the
relevance of these data, further research is required to determine
their biological meaning under stressful conditions (acidic,
oxidative and nutrient limited conditions). Moreover, host
susceptibility should be evaluated in order to clarify its role in
the pathogenesis of pediatric DU. Finally, it will be important to
characterize all of the differences in the proteome profile of DU-
and GU-associated H. pylori strains, to better understand the
divergence of these diseases.
Methods
Bacteria and cell growth conditions
A total of 10 H. pylori strains isolated from children attending the
pediatric gastroenterology units in the Lisbon area (Portugal) for
upper diagnostic gastrointestinal symptoms were analyzed. These
included five patients presenting NUD and five others with PUD
(one GU and four DU) (Table 1). None of the children had
received anti-H. pylori antibiotic or anti-secretory therapy prior to
endoscopy. All of the children suffering from PUD had no other
etiology for the disease. These strains belong to the collection of
bacterial strains of the Department of Infectious Diseases of the
National Institute of Health Dr. Ricardo Jorge, in Lisbon,
Portugal. Bacteria were grown in H. pylori selective medium
(Biogerm, Maia, Portugal) at 37uC in a microaerobic environment
(AnoxomatH, MART Microbiology BV, Drachten, The Nether-
lands) for 24 h. For motility and co-culture assays, a pool of the
five NUD strains and a pool of the five PUD strains were prepared
by mixing biomasses recovered from 24 h grow plates of each
strain (equal amount of each strain).
For co-culture assays, the NCI-N87 (ATCC CRL 5822) cell line
was grown at 37uC with 5% CO2 and 99% humidity in
Dulbecco’s modified Eagle’s medium (DMEM/F12) (Invitrogen,
Life Technologies, Carlsbad, CA, USA) supplemented with 10%
(v/v) of heat inactivated (56uC for 30 min) fetal bovine serum
(FBS) (Invitrogen).
Co-culture assays
A pool of the five NUD-associated strains and a pool of the five
PUD-associated strains were prepared in NCI-N87 cell growth
medium, and diluted to a final concentration of 16108 CFU/mL.
NCI-N87 cells grown on 8-well chamber slides (Nalge Nunc,
Roskilde, Denmark) for immunocytochemistry assays or on 24
multi-well plates (Nalge Nunc) for cellular viability determination,
until 80 to 90% confluence were rinsed twice with phosphate-
buffered saline (PBS) (Invitrogen) and fresh growth medium was
added. Bacterial pools were then added at a MOI of 100 and the
plates were maintained under NCI-N87 cell growth conditions.
Non-infected NCI-N87 cells were used as a control. At 1, 12 and
24 h post-infection, cells were analyzed by light microscopy and
stained using PAS (Sigma-Aldrich Co., St. Louis, MO, USA) and
hematoxylin (Sigma-Aldrich). Cell viability was determined using
the classical trypan blue exclusion test (Sigma-Aldrich).
Immunocytochemistry analysis
After co-culture with the pools of H. pylori strains, NCI-N87 cells
were rinsed twice with cold PBS and fixed for 30 min at 4uC in a
4% (v/v) formaldehyde (Sigma-Aldrich) and 3.7% (w/v) sucrose
(Merck, Darmstadt, Germany) solution, in PBS. After two washes
with PBS, cells were permeabilized for 15 min with 0.2% (v/v)
Triton X-100 (Sigma-Aldrich) in PBS at room temperature (RT),
washed three times more with PBS and blocked with 1% (w/v)
bovine serum albumin (BSA) in PBS for 30 min at RT, prior to
incubation for 2 h at 37uC with the anti-a-tubulin (clone DM1A)
(Sigma-Aldrich) monoclonal antibody (diluted 1:1000 in 0.5% (w/
v) BSA in PBS). Cells were then washed three times with PBS and
incubated for 1 h at 37uC with the fluorescein isothiocyanate
(FITC)-conjugated anti-mouse IgG (Sigma-Aldrich) diluted 1:100
and washed three times again. Cell slides were mounted in
Vectashield (Vector Laboratories, Burlingame, CA, USA) and
their immunofluorescence was observed and recorded on an
Axiovert 40CFL fluorescence microscope (Carl Zeiss, Jena,
Germany) equipped with an Axiocam MRc5 (Carl Zeiss) camera.
Images were processed with the software AxioVision Rel. 4.6.3
(Carl Zeiss).
2DE
Bacterial total protein extracts and their separation by 2DE was
performed as previously described [35]. Briefly, 800–1000 mg of
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protein in 450 mL re-hydration buffer were loaded onto 18 cm
Immobiline DryStrips (GE Healthcare, Uppsala, Sweden) with a
non-linear wide range pH gradient (pH 3–11). After active gel
strip re-hydration, IEF was run on an Ettan IPGphor 3 unit (GE
Healthcare) for a total of 100 kVh during which the voltage was
gradually increased up to 5,000 V for a total of 66 h. For SDS-
PAGE, the second dimension analysis, the proteins on the gel
strips were equilibrated by soaking the strip in equilibration buffer
for 15 min at RT and then for another 15 min in blocking buffer.
Strips were finally applied onto 7–16% (w/v) gradient polyacryl-
amide gels and run overnight at 1 W/gel (Ettan DALTsix System,
GE Healthcare). Protein visualization was carried out by CBB
staining (Sigma Aldrich).
2DE map analysis
CBB-stained 2DE gels were scanned in the ImageScanner (GE
Healthcare) operated by the software LabScan 5 (GE Healthcare)
in transparency mode with a red color filter. Scanning was carried
out at 300 dpi and 16 bit grayscale. Images were analyzed using
the ImageMasterTM 2D Platinum software (GE Healthcare) as
before [35], taking into account the standardized relative intensity
volume of spots (or % Vol, i.e. the volume of each spot over the
volume of all spots in the gel). Differences in protein abundance
among strains were statistically assessed. To assure result
reproducibility, all samples were subjected to 2DE twice, making
a total of 20 analyzed 2DE gels.
Sample preparation and mass spectrometry analysis
The selected differentially expressed proteins were identified by
PMF using an Autoflex III MALDI-TOF/TOF mass spectrom-
eter (Bruker Daltonics, Bremen, Germany), as previously reported,
with some minor modifications [35]. Protein spots were excised
from the CBB-stained 2DE gels and enzymatically digested in-gel
with proteomics grade porcine trypsin (Sigma-Aldrich). Trypsin-
digested peptides were loaded in a disposable ready-to-use
MALDI target prespotted with a-cyano-4-hydroxycinnaminic acid
(Prespotted AnchorChip PAC 384/96, Bruker Daltonics) and were
assayed with the mass spectrometer in the positive ion mode.
Spectra acquired with the FlexControl (Compass software, version
1.2, Bruker Daltonics) in reflection mode, were processed by using
FlexAnalysis (Compass software, version 1.2, Bruker Daltonics).
Monoisotopic peptide masses were used to search protein
databases (H. pylori NCBI nr. 2011.03.04, 13254464 sequences;
or Swissprot databases nr. 2010.10, 521016 sequences) using
MASCOT software (version 2.3.01, Matrix Science, London,
UK). A mass accuracy of 50–100 ppm and 1 missed cleavage were
allowed in the searches. In the absence of matches, the mass
window was extended up to 200 ppm. Cysteine carbamidomethy-
lation was considered as a fixed modification and protein N-
terminal acetylation, oxidation of methionine and pyroglutamic-
acid on N-terminal glutamic acid were allowed as variable
modifications. Proteins with significant MOWSE scores (p,0.05)
are reported. In a few special cases, MS identification based on
MOWSE scores with no statistical significance were also reported
and discussed since the same identification was obtained for the
equivalent spot from different 2DE gels and because it matched
the identification in the 2DE H. pylori database.
Motility assays
5 ml of each pool of H. pylori prepared as mention above, were
inoculated with a sterile pipette tip into motility agar plates,
consisting of brain-heart infusion (BHI) medium (Oxoid, Hamp-
shire, UK) supplemented with 5% (v/v) of heat-inactivated (56uC
for 30 min) FBS, H. pylori selective supplement (10 mg/L of
vancomycin, 5 mg/L of trimethoprim, 5 mg/L of cefsulodin and
5 mg/L of amphotericin B) (Oxoid) and 0.35% (w/v) agar.
Motility was scored by measuring the bacterial halo diameter at 5,
7 and 11 days of incubation of the plates under microaerobic
conditions (Campygen CN0025, Oxoid), at 37uC. Differences in
motility of the two pools of strains, tested in three independent
experiments, were statistically assessed.
Statistics
Whenever necessary, differences were tested by Student’s t test,
being considered as statistically significant when p,0.05. Results
are expressed as averages 6 standard deviations (SD) of n
observations.
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